abstract |
The present application relates to methods of administering Factor XII inhibitors to prevent, treat or ameliorate the effects of neuroinflammatory diseases such as multiple sclerosis and neuroinflammatory diseases such as multiple sclerosis. Also provided are agents that inhibit the activity of FXII and pharmaceutical compositions comprising the agent. |